Polly A. Murphy

Business address
C/O Atea Pharmaceuticals, Inc., 125 Summer Street, Boston, MA, 02110
Top holdings (ownership)
AVIR and CELC
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Polly A. Murphy has filed 16 SEC EDGAR filings since 29 Oct 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 24 Jun 2025 20 Jun 2025 001-39661
4 Open Document Open Filing 29 May 2025 24 Jun 2024 001-38207
4 Open Document Open Filing 21 May 2025 19 May 2025 001-38207
4 Open Document Open Filing 4 21 Jun 2024 21 Jun 2024 001-39661
4 Open Document Open Filing 4 18 Jun 2024 16 Jun 2024 001-39661
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 06 Jun 2024 04 Jun 2024 001-38207
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2023 16 Jun 2023 001-39661
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 17 May 2023 15 May 2023 001-38207
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 23 Nov 2022 22 Nov 2022 001-38207
3 Open Document Open Filing FORM 3 14 Sep 2022 12 Sep 2022 001-38207
4 Open Document Open Filing FORM 4 14 Sep 2022 12 Sep 2022 001-38207
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2022 17 Jun 2022 001-39661
4 Open Document Open Filing FORM 4 SUBMISSION 21 Dec 2021 20 Dec 2021 001-39661
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2021 18 Jun 2021 001-39661
4 Open Document Open Filing FORM 4 SUBMISSION 03 Nov 2020 03 Nov 2020 001-39661
3 Open Document Open Filing FORM 3 SUBMISSION 29 Oct 2020 29 Oct 2020 001-39661